
We take great responsibility to help improve patients’ lives and see ourselves as a vital link between our customers and their patients – together, we create a safe and innovative healthcare environment of tomorrow. Our state-of-the-art solutions for parenteral drug packaging are supplied to leading pharmaceutical and biotech companies worldwide.
At Datwyler, we are dedicated to meeting customer expectations by guaranteeing the highest level of quality and safety and continuing to make investments aimed at meeting the ever-changing regulatory requirements of the industry. Thanks to our sophisticated product know-how, high-quality manufacturing processes provided on a global scale, and our strong partnerships, we offer best-in-class solutions and enable our customers around the globe to realize their full healthcare potential.
Latest news

Datwyler Representative receives PDA Award 2022
Dr. Renaud Janssen, longtime Head of Technical Services at Datwyler, was recognized by PDA for his diverse and valuable contributions to the field of pharmaceutical packaging science with the Edward Smith Packaging Science Award.

Datwyler as first supplier of film and spray coatings for Healthcare components
Datwyler introduces its own film coating technology, becoming the first and sole supplier capable of offering both film and spray fluoropolymer coating technologies for elastomeric closures.

Sustainable healthcare solutions for the pharma industry
Datwyler’s award-winning sustainability work is helping the global pharmaceutical market transform into a greener, more environmentally friendly industry.

Datwyler adds steam sterilization option for ready-to-use components for injectable drugs
Datwyler will deliver RTU components in robust packaging guaranteeing a shelf life of 2 years after steam sterilization.

Datwyler recognized for Environmental Excellence by Pharmaceutical Technology
The Environmental category highlights companies that are undertaking projects that reduce their impact on the natural environment.
FirstLine® – Datwyler’s best-in-class manufacturing standard
Datwyler Healthcare CEO, Dirk Borghs, discusses Datwyler’s FirstLine® manufacturing standard, recent investments and expansions of the company’s global footprint, and its highest quality coated elastomers for sensitive drugs.
During Challenging Times, The Path to Patient Safety Starts with Datwyler.
At Datwyler, we put care, quality, and drug integrity first. Because we care.
Upcoming events

Ultra-low Extractable Formulations and Beyond: Different Coating Technologies and their Unique Benefits
Rubber components are often an essential part of the primary packaging system of parenteral drugs. This webcast aims to highlight the considerable evolution that was made regarding chemical cleanliness of rubber components and their impact on extractables and leachables.
Datwyler in the media

Mitigating container closure integrity challenges for injectables
Datwyler’s Eugene Polini discusses what steps drug manufacturers can take to ensure that primary packaging systems remain sealed for product’s entire shelf life.

Datwyler introduces film coating technology
Contract Pharma reports how Datwyler is the first supplier to offer both film and spray fluoropolymer coating technologies for elastomeric closures for injectable drugs.

Quality first: How pharma can meet injectables demand while staying compliant
The demand for injectable drugs is rising. Yet while demand for injectables soars, regulators are cracking down on quality requirements, forcing many pharma companies to examine the role – and risks – of their primary packaging.

“PERFECTing” the pharma packaging selection process
Gabrielle Gehron, Scientific Support Manager at Datwyler, explains how to successfully analyze your pharma packaging needs and navigate through the packaging selection process.
Datwyler adds steam sterilisation option for ready-to-use components for injectable drugs
Datwyler will deliver RTU components in robust packaging guaranteeing a shelf life of two years after steam sterilization.